APA استشهاد

Scholtes, R. A., van Baar, M. J., Lytvyn, Y., Bjornstad, P., Nieuwdorp, M., Cherney, D. Z., & van Raalte, D. H. (2019). Sodium glucose cotransporter (SGLT)-2 inhibitors: Do we need them for glucose-lowering, for cardiorenal protection or both? Diabetes Obes Metab.

استشهاد بنمط شيكاغو

Scholtes, Rosalie A., Michaël J.B van Baar, Yuliya Lytvyn, Petter Bjornstad, Max Nieuwdorp, David Z.I Cherney, و Daniël H. van Raalte. "Sodium Glucose Cotransporter (SGLT)-2 Inhibitors: Do We Need Them for Glucose-lowering, for Cardiorenal Protection or Both?" Diabetes Obes Metab 2019.

MLA استشهاد

Scholtes, Rosalie A., et al. "Sodium Glucose Cotransporter (SGLT)-2 Inhibitors: Do We Need Them for Glucose-lowering, for Cardiorenal Protection or Both?" Diabetes Obes Metab 2019.

تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.